(Q57313076)
Statements
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)- (English)
0 references
September 2009
0 references
158
0 references
3
0 references
335-341.e3
0 references